STERIS plc
STE- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001757898
In the last 90 days, STERIS plc insiders filed 0 open-market purchases and 2 sales; 841 institutions reported holding it in 13F filings for Q2 2026, worth $20.0B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:58 PM ET
Revenue flow, FY2026
Where the revenue went in FY2026, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | May 11, 2026 | May 14, 2025 | May 8, 2024 | May 10, 2023 | May 12, 2022 |
| Revenue | $5.94B | $5.46B | $5.14B | $4.96B | $4.59B |
| Cost of revenue | $3.31B | $3.06B | $2.92B | $2.80B | $2.57B |
| Gross profit | $2.63B | $2.40B | $2.22B | $2.16B | $2.02B |
| Operating expenses | $1.52B | $1.54B | $1.38B | $1.89B | $1.59B |
| Research and development | $112.9M | $107.6M | $103.7M | $101.6M | $87.9M |
| Selling, general and administrative | $1.41B | $1.33B | $1.25B | $1.30B | $1.50B |
| Operating income | $1.10B | $866.6M | $836.1M | $268.2M | $425.6M |
| Interest expense | – | – | $144.4M | $108.0M | $89.6M |
| Income tax | $262.2M | $184.7M | $149.5M | $51.5M | $71.6M |
| Net income | $782.3M | $614.6M | $378.2M | $107.0M | $243.9M |
| EPS, basic | $7.97 | $6.24 | $3.83 | $1.07 | $2.50 |
| EPS, diluted | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 |
| Weighted shares, basic | 98.2M | 98.6M | 98.8M | 99.7M | 97.5M |
| Weighted shares, diluted | 98.7M | 99.1M | 99.4M | 100.2M | 98.3M |
| Margins and growth | |||||
| Gross margin | 44.2% | 44.0% | 43.2% | 43.6% | 44.0% |
| Operating margin | 18.6% | 15.9% | 16.3% | 5.4% | 9.3% |
| Net margin | 13.2% | 11.3% | 7.4% | 2.2% | 5.3% |
| Revenue growth, year over year | +8.7% | +6.2% | +3.6% | +8.1% | +47.5% |
| Net income growth, year over year | +27.3% | +62.5% | +253.4% | −56.1% | −38.6% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | May 11, 2026 | May 14, 2025 | May 8, 2024 | May 10, 2023 | May 12, 2022 |
| Accounts receivable | $1.09B | $1.04B | $1.01B | $928.3M | $799.0M |
| Inventory | $631.8M | $581.3M | $674.5M | $695.5M | $575.0M |
| Total current assets | $2.39B | $2.00B | $2.87B | $2.01B | $1.88B |
| Property, plant and equipment | $2.16B | $1.96B | $1.77B | $1.71B | $1.55B |
| Goodwill | $4.19B | $4.10B | $4.07B | $3.88B | $4.40B |
| Intangible assets | $1.62B | $1.85B | $2.12B | $2.96B | $3.33B |
| Total assets | $10.7B | $10.1B | $11.1B | $10.8B | $11.4B |
| Accounts payable | $338.8M | $280.8M | $251.7M | $279.6M | $225.7M |
| Short-term debt | $118.9M | $125.0M | $85.9M | $60.0M | $142.9M |
| Total current liabilities | $1.15B | $1.02B | $931.1M | $861.8M | $922.2M |
| Long-term debt | $1.81B | $1.92B | $3.12B | $3.02B | $2.95B |
| Total liabilities | $3.54B | $3.53B | $4.75B | $4.73B | $4.88B |
| Shareholders' equity | $7.20B | $6.62B | $6.32B | $6.09B | $6.54B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | May 11, 2026 | May 14, 2025 | May 8, 2024 | May 10, 2023 | May 12, 2022 |
| Operating cash flow | $1.34B | $1.15B | $973.3M | $756.9M | $684.8M |
| Capital expenditures | $369.0M | $370.1M | $360.3M | $362.0M | $287.6M |
| Free cash flow | $972.4M | $778.0M | $612.9M | $395.0M | $397.2M |
| Depreciation and amortization | $486.5M | $476.2M | $565.2M | $552.9M | $553.1M |
| Stock-based compensation | $61.7M | $57.4M | $56.5M | $39.0M | $57.7M |
| Dividends paid | $241.8M | $219.9M | $200.6M | $183.5M | $163.2M |
| Share buybacks | $235.5M | $211.3M | $11.8M | $308.6M | $55.8M |
| Investing cash flow | -$512.5M | $388.8M | -$887.4M | -$383.3M | -$666.6M |
| Financing cash flow | -$568.2M | -$1.57B | -$85.2M | -$498.7M | $115.8M |
| Net change in cash | $267.9M | -$35.3M | -$1.34M | -$140.0M | $127.8M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.0% | 1.1% | 1.1% | 0.8% | 1.3% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.